MX9709872A - Formulaciones novedosas para suministro transdermico de pergolide. - Google Patents

Formulaciones novedosas para suministro transdermico de pergolide.

Info

Publication number
MX9709872A
MX9709872A MX9709872A MX9709872A MX9709872A MX 9709872 A MX9709872 A MX 9709872A MX 9709872 A MX9709872 A MX 9709872A MX 9709872 A MX9709872 A MX 9709872A MX 9709872 A MX9709872 A MX 9709872A
Authority
MX
Mexico
Prior art keywords
pergolide
composition
transdermal delivery
novel formulations
enhancer
Prior art date
Application number
MX9709872A
Other languages
English (en)
Other versions
MXPA97009872A (es
Inventor
Su Ii Yum
Melinda K Nelson
Patricia S Campbell
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of MX9709872A publication Critical patent/MX9709872A/es
Publication of MXPA97009872A publication Critical patent/MXPA97009872A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Composicion de materia para aplicacion a una superficie o mebrana del cuerpo para administrar pergolide mediante permeacion a través de la superficie o membrana del cuerpo; comprendiendo la composicion el pergolide que se va a administrar a un régimen terapéuticamente efectivo, solo o en combinacion con un incrementador con un incrementador de la permeacion o una mezcla de ellos; también están descritos dispositivos suministradores de fármaco que contienen pergolide o pergolide y la composicion incrementadora, y métodos para la administracion transdérmica del pergolide y de la composicion de pergolide/incrementador.
MXPA/A/1997/009872A 1995-06-07 1997-12-08 Formulaciones novedosas para suministrotransderico de pergolide MXPA97009872A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08473631 1995-06-07
US08/473,631 US6572879B1 (en) 1995-06-07 1995-06-07 Formulations for transdermal delivery of pergolide

Publications (2)

Publication Number Publication Date
MX9709872A true MX9709872A (es) 1998-08-30
MXPA97009872A MXPA97009872A (es) 1998-11-12

Family

ID=

Also Published As

Publication number Publication date
PT831827E (pt) 2007-07-20
CA2221263A1 (en) 1996-12-19
ATE361073T1 (de) 2007-05-15
JP2007238636A (ja) 2007-09-20
US6572879B1 (en) 2003-06-03
WO1996040139A1 (en) 1996-12-19
US6001390A (en) 1999-12-14
GB9724267D0 (en) 1998-01-14
JPH11507361A (ja) 1999-06-29
DE69637061D1 (de) 2007-06-14
DE69637061T2 (de) 2008-01-10
ES2285704T3 (es) 2007-11-16
EP0831827B1 (en) 2007-05-02
GB2316004A (en) 1998-02-18
EP1428527A1 (en) 2004-06-16
GB2316004B (en) 1999-08-04
DK0831827T3 (da) 2007-09-10
DE19681435T1 (de) 1998-07-23
US20040209909A1 (en) 2004-10-21
AU6476496A (en) 1996-12-30
EP0831827A1 (en) 1998-04-01

Similar Documents

Publication Publication Date Title
GB2316004B (en) Novel formulations for transdermal delivery of pergolide
CY2503B1 (en) Novel formulations for the transdermal administration of fluoxetine acetate and fluoxetine maleate.
MX9709162A (es) Composiciones mejoradas de la permeacion en la piel que usan lactilatos de acilo.
EP1243267A3 (en) Amoxycillin and clavulanate containing pharmaceutical formulation
WO1998017315A3 (en) Permeation enhancers for transdermal drug delivery compositions, devices, and methods
AU7396294A (en) Incorporating poly-n-vinyl amide in a transdermal system
RU94040387A (ru) Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
ZA946698B (en) Medical device for the administration of active ingredients or drugs at very low doses particularly homeopathic drugs
EP0429039A3 (en) Use of an opiate antagonist for the preparation of a pharmaceutical composition to be transdermally administered, and device for transdermal delivery
IL131561A0 (en) The use of buprenorphine in the preparation of a medicament for treating pain
ZA933349B (en) Transdermal administration of oxybutynin
GR3032523T3 (en) Therapeutic preparation for the transdermal administration of active substances
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
AU2313297A (en) Transdermally administered dextromethorphan as antitussive agent
DE69737723D1 (de) Behalter zur iontophoretischen verabreichung von medikamenten mit inerten material-bestandteilen
WO2000048445A3 (de) Pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit
EP1023901A4 (en) MEDICINES FOR HEPATITIS C AND THE USE THEREOF
AU3278800A (en) Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence
HK1036594A1 (en) Formulations for the transdermal administration offenoldopam.
AU2907800A (en) Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism
AU2503900A (en) Sulfated phosphatidylinositols, their preparation and use
GB0018322D0 (en) Pharmaceutical compositions
ES2184561A1 (es) Forma farmaceutica solida de administracion oral dispersable en agua para el tratamiento de la tuberculosis conteniendo refampicina, isoniazida, pirazinamida y piridoxina hidrocloruro, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica.